The core competencies of Nanotherapeutics are process development, quality control testing, and cGMP manufacture of preclinical and clinical stage biopharmaceutical bulk drug substance. We have considerable expertise in the application of a variety of platform technologies and traditional and proprietary delivery technologies. Our business model is designed to utilize these capabilities through partnerships with government and established companies.
We develop and manufacture high quality commercial products for our partners. In addition, we have been successful in obtaining government contracts and grants (over $1B to date) for the advanced development and manufacturing of biologics of importance to both healthcare and national security.
We invite conversations with interested parties to discuss their product development needs and our capabilities to meet those needs. Please contact us directly at: firstname.lastname@example.org